Bnp Paribas Teva Pharmaceutical Industries LTD Transaction History
Bnp Paribas
- $1.99 Trillion
- Q2 2024
A detailed history of Bnp Paribas transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bnp Paribas holds 700 shares of TEVA stock, worth $12,242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700
Previous 1,669
58.06%
Holding current value
$12,242
Previous $23.5 Million
51.7%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
604Shares Held
567MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$752 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$635 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$566 Million5.5% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.1MShares$509 Million7.9% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$504 Million3.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...